Tenaya Therapeutics(TNYA) - 2021 Q3 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) 171 Oyster Point Boulevard, 5th Floor South San Francisco, CA 94080 (Address of principal executive offices) (Zip Code) Delaware 81-3789973 (I.R.S. Employer Identification No.) (650) 825-6900 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly per ...